References
- Axelrod J, Tomchick R (1958). Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem, 233, 702-5.
- Chang I, Liu J, Majid S, et al (2012). Catechol-O-methyltransferasemediated metabolism of 4-hydroxyestradiol inhibits the growth of human renal cancer cells through the apoptotic pathway. Carcinogenesis, 33, 420-6. https://doi.org/10.1093/carcin/bgr294
- Dawling S, Roodi N, Mernaugh RL, Wang X, and Parl FF (2001). Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens, comparison of wild-type and variant COMT isoforms. Cancer Res, 61, 6716-22.
- Delort L, Chalabi N, Satih S, et al (2008). Association between genetic polymorphisms and ovarian cancer risk. Anticancer Res, 28, 3079-81.
- DeMille MM, Kidd JR, Ruggeri V, et al (2002). Population variation in linkage disequilibrium across the COMT gene considering promoter region and coding region variation. Hum Genet, 111, 521-37. https://doi.org/10.1007/s00439-002-0809-0
- Doherty JA, Weiss NS, Freeman RJ, et al (2005). Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev, 14, 357-66. https://doi.org/10.1158/1055-9965.EPI-04-0479
- Garner EI, Stokes EE, Berkowitz RS, et al (2002). Polymorphisms of the estrogen-metabolizing genes CYP17 and catechol-Omethyltransferase and risk of epithelial ovarian cancer. Cancer Res, 62, 3058-62.
- Goodman JE, Lavigne JA, Hengstler JG, et al (2000). Catechol-O-methyltransferase polymorphism is not associated with ovarian cancer risk. Cancer Epidemiol Biomarkers Prev, 9, 1373-6.
- Goodman MT, McDuffie K, Kolonel LN, et al (2001). Casecontrol study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism. Cancer Epidemiol Biomarkers Prev, 10, 209-16.
- Hennessy BT, Coleman RL, Markman M (2009). Ovarian cancer. Lancet, 374, 1371-82. https://doi.org/10.1016/S0140-6736(09)61338-6
- Hirata H, Hinoda Y, Okayama N, et al (2008). COMT polymorphisms affecting protein expression are risk factors for endometrial cancer. Mol Carcinog, 47, 768-74. https://doi.org/10.1002/mc.20432
- Holt SK, Rossing MA, Malone KE, et al (2007). Ovarian cancer risk and polymorphisms involved in estrogen catabolism. Cancer Epidemiol Biomarkers Prev, 16, 481-9. https://doi.org/10.1158/1055-9965.EPI-06-0831
- Jakubowska A, Gronwald J, Menkiszak J, et al (2010). BRCA1-associated breast and ovarian cancer risks in Poland, no association with commonly studied polymorphisms. Breast Cancer Res Treat, 119, 201-11. https://doi.org/10.1007/s10549-009-0390-5
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Jemal A, Siegel R, Ward E, et al (2009). Cancer statistics, 2009. CA Cancer J Clin, 59, 225-49. https://doi.org/10.3322/caac.20006
- Lachman HM, Papolos DF, Saito T, et al (1996). Human catechol-O-methyltransferase pharmacogenetics, description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics, 6, 243-50. https://doi.org/10.1097/00008571-199606000-00007
- Lajin B, Hamzeh AR, Ghabreau L, et al (2013). Catechol-Omethyltransferase Val 108/158 Met polymorphism and breast cancer risk: a case control study in Syria. Breast Cancer, 20, 62-6. https://doi.org/10.1007/s12282-011-0309-y
- Lundin E, Wirgin I, Lukanova A, et al (2012). Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer. Cancer Epidemiol, 36, 445-52. https://doi.org/10.1016/j.canep.2012.04.006
- McGrath M, Hankinson SE, Arbeitman L, et al (2004). Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility. Carcinogenesis, 25, 559-65.
- Millikan RC, Pittman GS, Tse CK, et al (1998). Catechol-Omethyltransferase and breast cancer risk. Carcinogenesis, 19, 1943-7. https://doi.org/10.1093/carcin/19.11.1943
- Ortashi O (2013). Gynecological cancer services in Arab countries: present scenario, problems and suggested solutions. Asian Pac J Cancer Prev, 14, 2147-50. https://doi.org/10.7314/APJCP.2013.14.3.2147
- Park BL, Shin HD, Cheong HS, et al (2009). Association analysis of COMT polymorphisms with schizophrenia and smooth pursuit eye movement abnormality. J Hum Genet, 54, 709-12. https://doi.org/10.1038/jhg.2009.102
- Sellers TA, Schildkraut JM, Pankratz VS, et al (2005). Estrogen bioactivation, genetic polymorphisms, and ovarian cancer. Cancer Epidemiol Biomarkers Prev, 14, 2536-43. https://doi.org/10.1158/1055-9965.EPI-05-0142
- Szyllo K, Smolarz B, Romanowicz-Makowska H, et al (2007). The risk of endometrial cancer appearance and CYP19 and COMT gene polymorphism. Pol Merkur Lekarski, 22, 208-10.
- Tao MH, Cai Q, Xu WH, et al (2006). Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and endometrial cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev, 15, 2570-3. https://doi.org/10.1158/1055-9965.EPI-06-0498
- Thompson PA, Shields PG, Freudenheim JL, et al (1998). Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res, 58, 2107-10.
- Wang SS, Morton LM, Bergen AW, et al (2007). Genetic variation in catechol-O-methyltransferase (COMT) and obesity in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial. Hum Genet, 122, 41-9. https://doi.org/10.1007/s00439-007-0374-7
- Yuzhalin AE, Kutikhin AG (2012). ABO and Rh blood groups in relation to ovarian, endometrial and cervical cancer risk among the population of South-East Siberia. Asian Pac J Cancer Prev, 13, 5091-6. https://doi.org/10.7314/APJCP.2012.13.10.5091
- Zhao XM, Xie MQ, Yang DZ, et al (2007). Polymorphism of catechol-O-methyltransferase gene in relation to the risk of endometrial cancer. Zhonghua Fu Chan Ke Za Zhi, 42, 116-9.
- Zimarina TC, Kristensen VN, Imianitov EN, and Bershtein LM (2004). Polymorphisms of CYP1B1 and COMT in breast and endometrial cancer. Mol Biol, 38, 386-93.
Cited by
- The Val158Met polymorphism in COMT gene and cancer risk: role of endogenous and exogenous catechols vol.49, pp.1, 2017, https://doi.org/10.1080/03602532.2016.1258075